What You Should Know:
- WellSky, a health and community care technology company, and Google Cloud have announced a strategic partnership to leverage cutting-edge cloud technologies and artificial intelligence (AI) to transform healthcare delivery across the continuum.
- The strategic collaboration aims to provide care providers with smarter tools, automate repetitive tasks, and ultimately, improve patient outcomes. Google Cloud's governance and privacy policies empower clients to retain
Read More
Most Popular
ECRI Unveils Top 10 Health Technology Hazards for 2024
What You Should Know:
- ECRI, an independent healthcare safety organization, has released its annual Top 10 Health Technology Hazards list for 2024, highlighting critical safety concerns for healthcare providers and the medical device industry.
- This year's list focuses on a diverse range of issues, from usability challenges of home medical devices to environmental impacts of patient care and the dangers of ransomware attacks.
Top 10 Health Technology Hazards for 2024
Here's a
Read More
State of Digital Health 2023: From Gold Rush to Consolidation in a Cooling Market
What You Should Know:
The year 2023 marked a stark shift for digital health, transitioning from the heady days of record-breaking funding to a harsh reality of tightening belts and consolidation, according to a new report from CB Insights.
- The CB Insights report, State of Digital Health 2023, reveals that while the pandemic initially fueled a gold rush of innovation, the tide has turned, leaving a landscape of both challenges and opportunities.
Funding Plummets, Deals Dry Up
Global
Read More
2023 Health IT Recap: M&A Shifts, VC Squeezes, and Market Trends
What You Should Know:
- After a decade of unchecked expansion, the health IT market faced a reality check in 2023, according to a new report from Healthcare Growth Partners.
- The report, January 2024 Health IT Market Review reveals runaway inflation, rising interest rates, and a tech valuation reset tempered investor enthusiasm and led to a correction in valuations across both M&A and investment activity. However, despite the challenges, there were signs of a rebound in late 2023,
Read More
M&A: General Catalyst’s HATCo to Acquire Summa Health
What You Should Know:
- Akron-based Summa Health and General Catalyst's Health Assurance Transformation Corporation (HATCo) have announced a planned acquisition that promises to reshape healthcare delivery in the region.
- This strategic acquisition marks the beginning of a long-term journey to create a more proactive, affordable, and equitable healthcare system for the Greater Akron community.
A Vision for a Healthier Future
Summa Health, a large, integrated healthcare system, and
Read More
Pilot Programs Tackle Insulin-Requiring Diabetes Challenges for Medicaid Beneficiaries
What You Should Know:
- Millions of Americans managing insulin-requiring diabetes (IRD) face a unique set of challenges, often compounded by social needs like food insecurity, housing instability, and financial stress. These factors can significantly impact their ability to effectively manage their condition and achieve optimal health outcomes.
- Recognizing this critical need, the Medicaid Innovation Collaborative (MIC) has launched pilot programs in Iowa, Kentucky, and New York,
Read More
The High Price of Living with Diabetes in 2024: A Breakdown of Costs
What You Should Know:
- The average person with diabetes could spend between $3,300 and $4,600 a year on out-of-pocket costs, including prescription medications, provider visits, over-the-counter supplies, and lost wages, according to a recent GoodRx report.
- The report, The True Cost of Diabetes takes into account medications, visits with healthcare providers, and blood sugar level monitoring, as well as costs for emergency room visits, hospital stays, and chronic complications for those
Read More
Veracyte Acquires C2i Genomics for $70M, Expanding into Minimal Residual Disease Detection
What You Should Know:
- Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
- Under the terms of the agreement, Veracyte will pay $70 million in Veracyte shares at closing, and up to an additional $25 million based on the achievement of future performance milestones over the next two years, payable in Veracyte shares or cash at Veracyte’s election.
- This strategic move positions Veracyte to
Read More
How AI is Changing the Conversation Around Hospital Denials – and Improving Financial Implications in the Process
Of the many complexities within the healthcare industry, medical necessity determinations can be the most challenging – and pose one of the greatest barriers to efficient revenue cycle processes and appropriate reimbursement. Complex medical necessity policies that differ between payer, diagnosis, and presentation have muddled utilization review (UR) and revenue cycle processes for years, driving waste and friction between providers and payers that has only intensified since the pandemic.
In
Read More
Amazon Unveils Health Condition Programs Making Chronic Condition Management Easier
What You Should Know:
- Amazon launches its new Health Condition Programs to simplify access to digital health benefits offered by insurance plans and employers.
- By partnering with companies like Omada Health, Amazon brings awareness and enrollment options directly to patients where they're already looking for health information. This collaboration targets conditions like diabetes prevention, diabetes management, and hypertension, impacting millions of Americans.
How Amazon’s Health
Read More
